Фармакоэкономические аспекты терапии шизофрении атипичным антипсихотиком сероквелем по данным ГБУЗ РПНД (г. Улан-Удэ)

Етобаева Инна Георгиевна, С А Лубсанова, Тыхеева Наталья Алексеевна et al. · Современные проблемы науки и образования · 2015

The article makes the pharmacoeconomic analysis of the drug Seroquel and its usage in comparison to the standard therapy including typical neuroleptics. During the research work 2 groups of patients have been defined: experimental group and a group for comparison. The basic therapy of patients who formed the experimental group contained atypical neuroleptic Seroquel while the patients from another group were treated by traditional neuroleptic Triftazinum. To identify the expenditures for patients’ treatment in this research an average medical expenditure per person has been calculated. It was composed of an average cost of pharmacotherapy per person, an average cost of doctor’s visit per person and an average cost of a bed per day at the in-patient department during the whole course of treatment. The results of the research proved that Seroquel is a very efficient and cost-effective medication because of reducing the relapse rate and shortening the hospitalization period and the number of medical consultations.

Cited by 0 works.

Authors